Allied Market Research
Loading...
0
New
New
2021
Bone Grafts And Substitutes Market

Bone Grafts and Substitutes Market by Product (Allografts, Bone Grafts Substitutes, and Cell Based Matrices) and Application (Spinal fusion, Trauma, Craniomaxillofacial, Joint Reconstruction, and Dental Bone Grafting): Global Opportunity Analysis and Industry Forecast, 2021–2028

A01446
Pages: 228
May 2021 | 24059 Views
   
Author(s) : Swapna Singh, Snehal Manjrekar , Onkar Sumant
Tables: 105
Charts: 40
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Bone Grafts And Substitutes Market

Request Now !

Bone Grafts and Substitutes Market Overview:

The global bone grafts and substitutes market was valued at $2,652.6 million in 2020, and is projected to reach $3,362.6 million by 2028, registering a CAGR of 4.3% from 2021 to 2028. Bone grafts are implantable materials, which promote bone healing, bone formation, and osseous reconstruction due to their osteoconductive, osteogenic, and osteoinductive properties. They are used in sports, trauma, plastic, facial, and spinal surgeries. In addition, they can be used to fill voids in case of absence of bones or help in provision of structural stability. Bone grafting is a surgical procedure for replacing a missing or defected bone with a material (bone graft) from a patient’s own body, cadaver, animals, or a different person. It finds its application in wound healing, complex fracture treatment, and others.

The growth of the global bone grafts and substitutes market is driven by factors such as rise in incidence of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft, and increase in demand for dental bone grafts. However, higher costs of surgeries and ethical issues related to bone grafting procedures are anticipated to limit the bone grafts and substitutes market growth. Conversely, increase in focus of key players toward R&D activities in bone grafts & their substitutes and upsurge in demand for orthopedic procedures among geriatric population are expected to provide lucrative opportunities for the market players in the future.

Bone-Grafts-and-Substitutes-Market

Get more information on this report : Request Sample Pages

COVID-19 Impact

The overall impact of COVID-19 pandemic is likely to remain fairly negative for medical devices companies in the bone grafts & substitutes industry. Companies are facing a set-back, owing to the lockdown, which has led to disruptions in the supply chain activities across the globe. Moreover, key players in the industry are facing issues with regard to the availability of human resource for manufacturing bone grafts & substitutes at production facilities. In addition, end users such as hospitals and clinics reported decline in patient visits due to the lockdown restrictions implemented worldwide. However, this situation is expected to improve as government has started relaxing norms around the world for resuming business activities. Moreover, the demand for bone grafts & substitutes is likely to increase post recommencing the elective surgeries and procedures in the near future.

Product Segment Review

By product, the bone grafts and substitutes market can be categorized into allografts, bone grafts substitute and cell-based matrices. The allografts are further bifurcated into machined allografts and demineralized bone matrix. The bone graft substitutes segment is further classified into bone morphogenic proteins (BMP) and synthetic bone grafts. The bone graft substitutes segment is expected to dominate the market during the forecast period. This is attributed to increase in prevalence of bone and joint disorders. In addition, these bone graft substitutes are used in varied applications such as bone replacement, posttraumatic skeletal conditions, and other bone-related problems. Moreover, advancements in bone graft materials and development of innovative products fuel the bone grafts and substitutes market growth.

Bone Grafts and Substitutes Market
By Type

Your browser does not support the canvas element.

Bone Graft Substitutes segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application Segment Review

By application, the bone grafts and substitutes market is segmented into spinal fusion, trauma, craniomaxillofacial, joint reconstruction and dental bone grafting. The spinal fusion segment is anticipated to be the largest growing segment over the analysis period. Spinal fusion is a condition in which a solid bridge is formed in between two vertebral segments of the spine. This bridge stops the movement in that area of spine. Bone graft and its substitutes provide the environment for the formation of this solid bridge. There has been a significant increase in the need of bone grafts for spinal fusion, owing to rise in incidence of spinal disorders and presence of a wide range of products for spinal fusion. Bone grafts and substitutes such as demineralized bone matrix and tricalcium phosphate are used as graft extenders that have capability of replacing need of autograft in spinal fusion. Autografts are best suited grafts for spinal fusion; however, the risk of chronic pain reduces their usage to a certain extent. Moreover, rise in incidence of patients suffering from rheumatoid arthritis, osteoarthritis, and other joint disorders fuels the demand for joint reconstruction procedures. Availability of specialized products such as vascularized free bone grafts and structural bone grafts, including femoral head grafts have further increased the usage of bone grafts in joint reconstruction applications.

Bone Grafts and Substitutes Market
By Application

Your browser does not support the canvas element.

Spinal Fusion segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Region segment review

North America is leading the global bone grafts and substitutes market owing to upsurge in geriatric population coupled with bone related disorders and deformities. For instance, as per the report published by Centers for Disease Control and Prevention (CDC), in 2017, around 60% of the elderly population in the U.S. suffered from spinal disorders. The European bone graft and substitutes market is predicted to witness stable growth throughout the forecast period with the rise in popularity of bone graft & substitutes products over autografts, and shifting trend toward minimally invasive surgeries. Asia-Pacific is expected to witness highest market growth rate, driven by growth in population, increase in affordability, and improvement in healthcare facilities in the region.

Bone Grafts and Substitutes Market
By Region

2028
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

List Of Key Companies

  • Arthrex Inc.
  • Baxter International Inc.
  • Integra Life Sciences Holdings Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic Plc.
  • Musculoskeletal Transplant Foundation
  • NuVasive Inc.
  • Stryker Corporation
  • Xtant Medical Holdings Inc.
  • Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current bone grafts and substitutes market trends and forecast estimations from 2020 to 2028, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • The projections in this report are made by analyzing the current trends and future bone grafts and substitutes market potential from 2021 to 2028, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the bone grafts and substitutes market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the bone grafts & substitutes market.

Key Segments Covered in the Report

By Product

  • Allografts
    • Machined allografts
    • Demineralized bone matrix
  • Bone Grafts Substitutes
    • Bone morphogenic proteins (BMP) 
    • Synthetic bone grafts
  • Cell based matrices

By Application

  • Spinal fusion
  • Trauma 
  • Craniomaxillofacial 
  • Joint reconstruction
  • Dental bone grafting

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Israel
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market share analysis, 2020
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in incidences of musculoskeletal conditions
3.4.1.2.Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3.Development of biocompatible synthetic bone grafts
3.4.1.4.Obesity and diabetes to increase the risk of degenerative joint diseases

3.4.2.Restraints

3.4.2.1.High cost of surgeries
3.4.2.2.Ethical issues related with bone grafting procedures

3.4.3.Opportunities

3.4.3.1.Emerging markets to offer lucrative growth opportunities

3.5.Government Regulations

3.5.1.FDA
3.5.2.Health Canada
3.5.3.CE Mark
3.5.4.Ministry of Health, Labor and Welfare (MHLW)
3.5.5.Therapeutic Goods Administration (TGA)

3.6.Reimbursement Scenario

3.6.1.U.S.
3.6.2.Europe
3.6.3.Asia-Pacific
3.6.4.LAMEA

3.7.COVID-19 Impact analysis on the market

CHAPTER 4:BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Allografts

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.2.5.Machined Allografts

4.2.5.1.Market size and forecast

4.2.6.Demineralized Bone Matrix (DBM)
4.2.6.1.Market size and forecast

4.3.Bone Graft Substitutes

4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.3.5.Bone Morphogenic Proteins (BMP)

4.3.5.1.Market size and forecast

4.3.6.Synthetic Bone Grafts

4.3.6.1.Market size and forecast

4.4.Cell-based Matrices (CBM)

4.4.1.Key market trends, growth factors and opportunities
4.4.1.1.Cell-based matrices-major products
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Spinal Fusion

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Trauma

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Craniomaxillofacial Surgery

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Joint Reconstruction

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

5.6.Dental Bone Grafting

5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:BONE GRAFTS & SUBSTITUTES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. Bone grafts & substitutes market by type
6.2.2.1.2.U.S. Bone grafts & substitutes market by application

6.2.2.2.Canada

6.2.2.2.1.Canada Bone grafts & substitutes market by type
6.2.2.2.2.Canada Bone grafts & substitutes market by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico Bone grafts & substitutes market by type
6.2.2.3.2.Mexico Bone grafts & substitutes market by application

6.2.3.Market size and forecast, by type
6.2.4.Market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany Bone grafts & substitutes market by type
6.3.2.1.2.Germany Bone grafts & substitutes market by application

6.3.2.2.France

6.3.2.2.1.France Bone grafts & substitutes market by type
6.3.2.2.2.France Bone grafts & substitutes market by application

6.3.2.3.Italy

6.3.2.3.1.Italy Bone grafts & substitutes market by type
6.3.2.3.2.Italy Bone grafts & substitutes market by application

6.3.2.4.Spain

6.3.2.4.1.Spain Bone grafts & substitutes market by type
6.3.2.4.2.Spain Bone grafts & substitutes market by application

6.3.2.5.UK

6.3.2.5.1.UK Bone grafts & substitutes market by type
6.3.2.5.2.UK Bone grafts & substitutes market by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe Bone grafts & substitutes market by type
6.3.2.6.2.Rest of Europe Bone grafts & substitutes market by application

6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan Bone grafts & substitutes market, by type
6.4.2.1.2.Japan Bone grafts & substitutes market, by application

6.4.2.2.China

6.4.2.2.1.China Bone grafts & substitutes market, by type
6.4.2.2.2.China Bone grafts & substitutes market, by application

6.4.2.3.India

6.4.2.3.1.India Bone grafts & substitutes market, by type
6.4.2.3.2.India Bone grafts & substitutes market, by application

6.4.2.4.Australia

6.4.2.4.1.Australia Bone grafts & substitutes market, by type
6.4.2.4.2.Australia Bone grafts & substitutes market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea Bone grafts & substitutes market, by type
6.4.2.5.2.South Korea Bone grafts & substitutes market, by application

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific Bone grafts & substitutes market, by type
6.4.2.6.2.Rest of Asia-Pacific Bone grafts & substitutes market, by application

6.4.3.Asia-Pacific Bone grafts &substitutes market, by type
6.4.4.Asia-Pacific Bone grafts & substitutes market, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil bone grafts & substitutes market, by type
6.5.2.1.2.Brazil bone grafts & substitutes market, by application

6.5.2.2.Israel

6.5.2.2.1.Israel bone grafts & substitutes market, by type
6.5.2.2.2.Israel bone grafts & substitutes market, by application

6.5.2.3.Saudi Arabia

6.5.2.3.1.Saudi Arabia bone grafts & substitutes market, by type
6.5.2.3.2.Saudi Arabia bone grafts & substitutes market, by application

6.5.2.4.South Africa

6.5.2.4.1.South Africa bone grafts & substitutes market, by type
6.5.2.4.2.South Africa bone grafts & substitutes market, by application

6.5.2.5.Rest of LAMEA

6.5.2.5.1.Rest of LAMEA bone grafts & substitutes market, by type
6.5.2.5.2.Rest of LAMEA bone grafts & substitutes market, by application

6.5.3.Market size and forecast, by type
6.5.4.Market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.ARTHREX, INC.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product Portfolio

7.2.BAXTER INTERNATIONAL INC.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product Portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments

7.3.INTEGRA LIFESCIENCES HOLDINGS CORPORATION

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product Portfolio
7.4.5.Business performance

7.5.MEDTRONIC PLC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.MUSCULOSKELETAL TRANSPLANT FOUNDATION

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product Portfolio

7.7.NUVASIVE, INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product Portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.STRYKER CORPORATION

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.XTANT MEDICAL HOLDINGS, INC.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product Portfolio
7.9.5.Business performance

7.10.ZIMMER BIOMET HOLDINGS, INC.,

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance

LIST OF TABLES

TABLE 01.BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020 2028 ($MILLION)
TABLE 02.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFT, BY TYPE 2020-2028 ($MILLION)
TABLE 03.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION 2020-2028 ($MILLION)
TABLE 04.BONE GRAFTS & SUBSTITUTES MARKET FOR MACHINED ALLOGRAFTS, BY REGION , 2020-2028 ($MILLION)
TABLE 05.BONE GRAFTS & SUBSTITUTES MARKET FOR DEMINERALIZED BONE MATRIX, BY REGION, 2020-2028 ($MILLION)
TABLE 06.BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2020-2028
TABLE 07.BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2020-2028
TABLE 08.BONE GRAFTS & SUBSTITUTES MARKET FOR BONE MORPHOGENETIC PROTEIN, BY REGION, 2020-2028 ($MILLION)
TABLE 09.BONE GRAFTS & SUBSTITUTES MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020 & 2028 ($MILLION)
TABLE 10.CELL-BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
TABLE 11.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2020 & 2028 ($MILLION)
TABLE 12.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 ($MILLION),
TABLE 13.BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020 & 2028 ($MILLION)
TABLE 14.BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 15.BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY REGION 2020 & 2028 ($MILLION)
TABLE 16.BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY REGION 2020 & 2028 ($MILLION)
TABLE 17.BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 18.BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2020 & 2028 ($MILLION)
TABLE 19.BONE GRAFTS & SUBSTITUTES MARKET, BY REGION, 2020 - 2028 ($MILLION)
TABLE 20.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 21.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 22.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 23.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 24.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 25.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 26.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 27.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 28.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021–2028 ($MILLION)
TABLE 29.EUROPE BONE GRAFTS & SUBSTITUTES, BY COUNTRY 2020–2028 ($MILLION)
TABLE 30.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 31.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 33.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 34.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 35.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 36.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 37.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 38.UK BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 39.UK BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 40.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 41.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 42.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 43.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 44.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 45.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 46.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 48.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 49.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 50.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 51.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 52.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 53.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 54.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 56.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 58.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 59.LAMEA BONE GRAFTS & SUBSTITUTES, BY COUNTRY ($MILLION), 2020–2028
TABLE 60.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 61.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 62.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 63.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021–2028 ($MILLION)
TABLE 64.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 65.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 66.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 67.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 68.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 69.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 70.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020–2028 ($MILLION)
TABLE 71.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020–2028 ($MILLION)
TABLE 72.ARTHREX: COMPANY SNAPSHOT
TABLE 73.ARTHREX: PRODUCT CATEGORIES
TABLE 74.ARTHREX: PRODUCT PORTFOLIO
TABLE 75.BAXTER: COMPANY SNAPSHOT
TABLE 76.BAXTER: BUSINESS UNITS
TABLE 77.BAXTER: PRODUCT PORTFOLIO
TABLE 78.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79.INTEGRA: COMPANY SNAPSHOT
TABLE 80.INTEGRA: OPERATING SEGMENTS
TABLE 81.INTEGRA: PRODUCT PORTFOLIO
TABLE 82.J&J: COMPANY SNAPSHOT
TABLE 83.J&J: OPERATING SEGMENTS
TABLE 84.J&J: PRODUCT PORTFOLIO
TABLE 85.MEDTRONIC: COMPANY SNAPSHOT
TABLE 86.MEDTRONIC: OPERATING SEGMENTS
TABLE 87.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 90.MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 91.MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 92.NUVASIVE: COMPANY SNAPSHOT
TABLE 93.NUVASIVE: PRODUCT LINE
TABLE 94.NUVASIVE: PRODUCT PORTFOLIO
TABLE 95.NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.STRYKER: COMPANY SNAPSHOT
TABLE 97.STRYKER: OPERATING SEGMENTS
TABLE 98.STRYKER: PRODUCT PORTFOLIO
TABLE 99.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.XTNT: COMPANY SNAPSHOT
TABLE 101.XTNT: OPERATING SEGMENTS
TABLE 102.XTNT: PRODUCT PORTFOLIO
TABLE 103.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 104.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 105.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 02.TOP INVESTMENT POCKETS: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 01.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2018–2021*
FIGURE 02.TOP WINNING STRATEGIES: BY DEVELOPMENT, 2018-2021* (%)
FIGURE 03.TOP WINNING STRATEGIES: BY COMPANY, 2018-2021* (%)
FIGURE 01.MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2020
FIGURE 02.MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2020
FIGURE 03.MARKET SHARE ANALYSIS: DEMINERALISED BONE MATRIX, 2020
FIGURE 04.MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2020
FIGURE 05.MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2020
FIGURE 06.MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2020
FIGURE 07.MARKET DYNAMICS
FIGURE 08.BONE GRAFTS & SUBSTITUTES MARKET: BY PRODUCT TYPE
FIGURE 09.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY COUNTRY,  2020 & 2028(%)
FIGURE 10.COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY COUNTRY,  2020 & 2028 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY COUNTRY,  2020 & 2028 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.BAXTER: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 20.INTEGRA: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.J&J: REVENUE, 2018–2020 ($MILLION)
FIGURE 24.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29.NUVASIVE: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.NUVASIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.NUVASIVE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.STRYKER: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.XTNT: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.XTNT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.XTNT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.ZIMMER BIOMET: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)

 
 

The utilization of bone graft & substitutes is expected to witness a significant rise with increase in diagnosis of orthopedic disorders and trauma cases. The bone grafts & substitutes market has piqued the interest of healthcare providers owing to several benefits offered by these devices to treat orthopedic disorders and improve the quality of life of the patients. There have been remarkable technological advancements in these devices to provide advanced treatment options. While the market is growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players.

Increase in musculoskeletal conditions, advancements in medical technology leading to a shift from autograft to allograft, increased preference for biocompatible bone grafts are key factors that contribute toward the growth of the market worldwide. In addition, increase in cases of lifestyle disorders such as diabetes and obesity add to the risk of developing degenerative joint diseases that further fuel the growth of the market. The major restraints of this market are ethical issues related to bone grafting and high cost of surgeries.

Emerging markets are gaining importance for majority of the manufacturers and distributors in the bone grafts & substitutes market. The need for improved healthcare services in emerging nations has resulted in a significant growth in shipment of these devices, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. North America is expected to dominate the market, followed by Europe.
 

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. No, there is no value chain analysis provided in the bone graft & substitutes Market report

A. Yes, bone graft & substitutes companies are profiled in the report

A. The top companies that hold the market share in bone graft & substitutes Market are Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Musculoskeletal Transplant Foundation, NuVasive, Inc., Stryker Corporation, Xtant Medical Holdings, Inc., Zimmer Biomet Holdings, Inc.

A. The total market value of bone graft & substitutes Market is $2,652.6 million in 2020

A. The key trends in the bone graft & substitutes Market are increase in usage of allograft and advantages bone grafting techniques over other conventional methods

A. The market value of bone graft & substitutes Market in 2020 was $2,503.5 Million

A. The forecast period in the report is from 2021 to 2028

A. The base year for the report is 2020

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Bone Grafts And Substitutes Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers